Literature DB >> 21628071

t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.

Jad J Wakim, Carlos A Tirado, Weina Chen, Robert Collins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21628071     DOI： 10.1016/j.leukres.2011.05.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  11 in total

1.  8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report.

Authors:  Jing Jing Liu; Li Meng
Journal:  Exp Ther Med       Date:  2018-06-20       Impact factor: 2.447

2.  Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.

Authors:  Andrew Chase; Catherine Bryant; Joannah Score; Nicholas C P Cross
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

Review 3.  Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.

Authors:  Jason Gotlib
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

4.  Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.

Authors:  M S Khodadoust; B Luo; B C Medeiros; R C Johnson; M D Ewalt; A S Schalkwyk; C D Bangs; A M Cherry; S Arai; D A Arber; J L Zehnder; J Gotlib
Journal:  Leukemia       Date:  2015-06-09       Impact factor: 11.528

5.  Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.

Authors:  Christina B Duckworth; Linsheng Zhang; Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

6.  A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation.

Authors:  Alexios Matikas; Ifigeneia Tzannou; Dimitra Oikonomopoulou; Maria Bakiri
Journal:  BMJ Case Rep       Date:  2013-03-20

7.  Chronic myelogenous leukemia-like hematological malignancy with t(8;22) in a 26-year-old pregnant woman: A case report.

Authors:  You-Wen Qin; Yi-Ning Yang; Ping Bai; Chun Wang
Journal:  Oncol Lett       Date:  2016-04-27       Impact factor: 2.967

8.  Acute progression of BCR-FGFR1 induced murine B-lympho/myeloproliferative disorder suggests involvement of lineages at the pro-B cell stage.

Authors:  Mingqiang Ren; Josephine A Tidwell; Suash Sharma; John K Cowell
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

9.  Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Isabel S Jerchel; Alex Q Hoogkamer; Ingrid M Ariës; Judith M Boer; Nicolle J M Besselink; Marco J Koudijs; Rob Pieters; Monique L den Boer
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

10.  Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia.

Authors:  Karl Haslam; Stephen E Langabeer; Johanna Kelly; Natasha Coen; Niamh M O'Connell; Eibhlin Conneally
Journal:  Case Rep Hematol       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.